Table of Contents
Global Market Watch:
BRICSS Cardiac Resynchronization Therapy (CRT) Devices market value is expected to reach US$455 million by 2016, primarily supported by the product types - Cardiac Resynchronization Therapy Defibrillator (CRT-D) and Cardiac Resynchronization Pacemakers (CRT-P). China accounts for nearly 25% of the market share and India claims more than 23%. In terms of CAGR, China is the fastest growing region while India and South Korea are just behind. Among the product types, Cardiac Resynchronization Therapy Defibrillator (CRT-D) accounts more nearly half of the market value while Cardiac Resynchronization Pacemakers (CRT-P) segments add up to the remaining half.
Healthcare Industry division has been witnessing a drastic change regarding the new innovation and technology which in terms are applied in improving from sector to sector since the past 3-5 years. Cardiovascular industry growth continues to increase with the presence of multiple technologies such as advanced material and software which is featured in most of the devices. International companies tends to innovate, develop new products and to enhance the existing features in cardiovascular devices.
The report ‘Cardiac Resynchronization Therapy (CRT) Devices - Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2012-2018’ reviews the latest trends in cardiovascular devices with a perceptive attempt to disclose the near-future growth prospects. An in-depth analysis on a geographic basis provides strategic business intelligence for healthcare sector investments. The study reveals profitable investment strategies for market start-ups, pharmaceutical/biotechnology companies, laboratories, Contract/Clinical/Commercial Research Organizations (CROs), government/academic organizations, consulting firms, database buyers and many more in preferred locations. The report primarily focuses on:
• Emerging Market Trends
• Advancements in the Technological Space
• Market Demand of The Segments (By-Region)
• Key Growth Areas and Market Size
• Region-Wise Demand Factor
• Key Competitors Edge
• Investment Strategies
The analysis primarily deals with by type. Further, the subdivided categories include:
Cardiac Resynchronization Therapy (CRT) Devices – By Type
a. Cardiac Resynchronization Therapy Defibrillator (CRT-D)
b. Cardiac Resynchronization Pacemakers (CRT-P)
The period considered for the cardiac resynchronization therapy (CRT) devices market analysis is 2012-2018. The region wise distribution of the market consists of BRICSS (Brazil, Russia, India, China, South Korea and South Africa).
More than 727 market players are identified in cardiovascular devices industry out of which 122 key companies that project improved market activities in the near future are profiled. The report consists of 103 data charts describing the market shares, sales forecasts and growth prospects. Moreover, key strategic activities in the market including mergers/acquisitions, collaborations/partnerships, product launches/developments are discussed.
Estimates are based on online surveys using customized questionnaires by our research team. Besides information from government databases, company websites, press releases & published research reports are also used for estimates.
Get Industry Insights. Simply.
Talk to Veronica
+1 718 514 2762
The active implantable medical devices market is estimated to grow at a CAGR of 7.8% from 2017 to 2022, to reach USD 26.75 billion by 2022 from USD 18.42 billion in 2017. The growth of this market is mainly ...
This report analyzes the worldwide markets for Electrodes for Medical Devices in US$ Thousand by the following Segments: Blood Gas Electrodes, Defibrillator Electrodes, ECG Electrodes, EEG/EMG/ENG Electrodes, ...
Defibrillator devices are class of medical devices used for delivering shock in a controlled and automated manner. These devices are mainly used for therapeutic purposes in cardiovascular critical care ...